Tech & Innovation
Volkswagen and Uber (UBER) announced a long‑term strategic partnership to deploy thousands of fully autonomous, all‑electric ID. Buzz AD vehicles across U.S. markets, with testing set to begin in late 2025 and a commercial launch planned in Los Angeles for 2026.
Planet Labs PBC (PL) secured a three‑year agreement with EMDYN to deliver near‑daily satellite imagery for enhanced anomaly detection and real‑time monitoring, strengthening its role in earth observation.
Xiao‑I Corporation (AIXI) reported robust progress in its AI‑powered glasses division after selling over 1,500 units since its August 2024 launch, reinforcing its 2025 revenue target of $12–15 million.
Coursera (COUR) posted strong Q1 2025 financial results, with revenue reaching $179.3 million – up 6% year‑over‑year – and welcomed a record 7.1 million new registered learners, elevating its total to 175.3 million. The education technology leader also updated its full‑year revenue guidance.
Perfect Corp. (PERF) was named “AI Company of the Year” at the 2025 RetailTech Breakthrough Awards for its innovative AI Skin Analysis technology, which delivers real‑time, dermatologist‑grade assessments across 15 skin concerns.
Corporate Financial & Market Moves
UPS (UPS) signed a definitive agreement to acquire Andlauer Healthcare Group for CAD $2.2 billion (USD $1.6 billion), reinforcing its global cold chain and healthcare logistics network.
Carpenter Technology (CRS) reported record Q3 FY2025 results with operating income of $137.8 million and EPS of $1.88, highlighting efficient operations and an active share repurchase program.
Rezolve Ai (RZLV) surged past $50 billion in GMV early in 2025, expanding its enterprise client roster and demonstrating strong platform momentum amid fierce competition.
Pagaya (PGY) executed its ninth consecutive $500 million AAA‑rated ABS deal, reflecting robust investor confidence and a buoyant capital markets environment.
VinFast Auto (Nasdaq: VFS) reported strong Q4 and full‑year 2024 results with Q4 EV deliveries of 53,139 units (up 143% QoQ) and annual deliveries of 97,399 units (up 192% YoY), despite posting substantial annual losses.
Skechers (NYSE: SKX) posted record Q1 2025 sales of $2.41 billion, with international markets contributing 65% of total sales and diluted EPS reaching $1.34.
Knowles (NYSE: KN) reported Q1 2025 revenues of $132.2 million along with a gross profit of $53.3 million and executed share repurchases worth $5 million, while reducing debt by $15 million.
Five Point Holdings (NYSE: FPH) delivered robust Q1 2025 results with consolidated net income of $60.6 million and revenues of $13.2 million. The Great Park Venture achieved significant sales, moving 325 homesites for $278.9 million and generating distributions of $143.3 million.
Boston Beer Company (NYSE: SAM) recorded a strong first quarter with net revenue up 6.5% to $453.9 million and net income surging 93.8% to $24.4 million. Improved gross margins and active share repurchases further reinforced its financial strength.
SES AI (NYSE: SES) reported Q1 2025 results with record quarterly revenue of $5.8 million and announced a $30 million share buyback program. The company also previewed its upcoming launch of a Molecular Universe software platform designed for advanced battery chemistries.
Healthcare & Biotech Innovations
Dyne Therapeutics (DYN) secured European orphan drug designation for its investigational therapy DYNE‑251 targeting Duchenne muscular dystrophy, potentially ensuring 10 years of market exclusivity.
Guardant Health (GH) entered a multi‑year collaboration with Pfizer to integrate its Guardant Infinity™ liquid biopsy platform into global oncology trials, advancing personalized cancer care.
Hologic (HOLX) is set to unveil data on its AI‑powered Genius AI® Detection 2.0 mammography system, which could reduce radiologists’ reading times by up to 24%, marking a potential breakthrough in early cancer detection.
NeuroSense Therapeutics (NRSN) shared positive Phase 2b PARADIGM study results for its ALS treatment program, with a 33% slowing of disease progression and a 58% improvement in survival rates as it prepares for a Phase 3 trial later in 2025.
Rafael Holdings (NYSE: RFL) announced that CEO Bill Conkling will step down and transition to an advisory role, as the company shifts its focus toward Trappsol® Cyclo™ after its merger with Cyclo Therapeutics. The move sets the stage for the ongoing Phase 3 clinical trial of its potential NPC1 treatment.
Caribou Biosciences (CRBU) unveiled a strategic pipeline reprioritization centered on its oncology programs CB‑010 and CB‑011, coupled with a 32% workforce reduction to extend its cash runway into H2 2027.
Energy, Sustainability & Other Highlights
AEP Texas (AEP) received approval for a three‑year, $318 million infrastructure resiliency plan aimed at bolstering distribution networks and wildfire prevention measures across its service region.
Amprius Technologies (AMPX) introduced its groundbreaking SiCore™ battery with an impressive energy density of 450 Wh/kg, promising up to 80% more energy than traditional lithium‑ion cells and setting a new standard for next‑generation energy storage.
Healthpeak Properties (DOC) and Hines announced a strategic partnership to develop the residential components of the Cambridge Point mixed‑use district in Cambridge, Massachusetts, a project offering up to 5 million square feet of development adjacent to key transit.
Sikorsky and Bristow Group (VTOL) finalized a long‑term agreement to support Bristow’s fleet of over 60 S‑92® helicopters through Sikorsky’s Total Assurance Program, which includes a Power‑by‑the‑Hour model and enhanced global support to extend service life and optimize operating costs.
